Abstract
Multiple system atrophy is a neurodegenerative disorder (one of the atypical parkinsonian syndromes) characterized by the presence of akinetic-rigid parkinsonism, cerebellar ataxia, autonomic failure, and pyramidal signs. Other features include REM sleep behavior disorder, respiratory stridor, disproportionate anterocollis, orofacial dystonia, and mood disorder. There are no diagnostic tests available. There are also no disease-modifying treatments. Treatment is symptomatic. This chapter will review clinical diagnosis and the roles of levodopa, botulinum toxin injections, nonmedical and medical approaches to urinary incontinence, constipation and orthostatic hypotension, as well as antidepressants and anxiolytics for symptomatic treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Reading
Ben-Shlomo Y, Wenning GK, Tison F, Quinn NP. Survival of patients with pathologically proven multiple system atrophy: a meta-analysis. Neurology. 1997;48:384.
Brooks DJ, Seppi K. Neuroimaging working group on MSA. Proposed neuroimaging criteria for the diagnosis of multiple system atrophy. Mov Disord. 2009;24:949.
Esper CD, Factor SA. Current and future treatments of multiple system atrophy. Curr Treat Options Neurol. 2007;9(3):210–23.
Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008;71:670.
Iranzo A, Santamaría J, Rye DB, et al. Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD. Neurology. 2005;65:247.
Jellinger KA, Lantos PL. Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update. Acta Neuropathol. 2010;119:657.
Murphy MA, Friedman JH, Tetrud JW, Factor SA. Neurodegenerative disorders mimicking progressive supranuclear palsy: a report of three cases. J Clin Neurosci. 2005;12:941.
Parikh SM, Diedrich A, Biaggioni I, Robertson D. The nature of the autonomic dysfunction in multiple system atrophy. J Neurol Sci. 2002;200:1.
Revuelta GJ, Benatar M, Freeman A, Wichmann T, Jinnah HA, DeLong MR, Factor SA. Clinical subtypes of anterocollis in parkinsonian syndromes. J Neurol Sci. 2012;315:100–3.
Wenning GK, Colosimo C, Geser F, Poewe W. Multiple system atrophy. Lancet Neurol. 2004;3:93.
Wenning GK, Geser F, Krismer F, et al. The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol. 2013;12:264.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Factor, S.A. (2019). Treatment of Multiple System Atrophy. In: Reich, S., Factor, S. (eds) Therapy of Movement Disorders. Current Clinical Neurology. Humana, Cham. https://doi.org/10.1007/978-3-319-97897-0_33
Download citation
DOI: https://doi.org/10.1007/978-3-319-97897-0_33
Published:
Publisher Name: Humana, Cham
Print ISBN: 978-3-319-97896-3
Online ISBN: 978-3-319-97897-0
eBook Packages: MedicineMedicine (R0)